Allworth Financial’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
Allworth Financial's CLPT Position: Q3 2026 in Review
Allworth Financial increased its ClearPoint Neuro (CLPT) stake by 36% in Q3 2026, buying an estimated $405 and bringing the position to 101 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #4900.
Allworth Financial first reported a position in CLPT in Q3 2022 and has held it in 17 quarters since. The position peaked at $45K in Q3 2025. 126 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.
- Allworth Financial held 101 shares of ClearPoint Neuro worth $1.23K as of Q3 2026.
- Allworth Financial bought 27 ClearPoint Neuro shares in Q3 2026, an estimated $405.
- ClearPoint Neuro made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4900 holding.
- Allworth Financial first reported a position in ClearPoint Neuro in Q3 2022 and has held it in 17 quarters since.
- Allworth Financial's ClearPoint Neuro position peaked at $45K in Q3 2025.
- 126 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.
Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.